EUVIMEDEUVIMED entdecken
Crossref

Tamoxifen Loaded Conjugate of Self‐Assembled Fluorescent Organic Nanoparticle and Vesicle for p53‐Activated Breast Cancer Therapy

Debolina Basu, Kathakoli Roy, Prasanta Kumar Das iD

Macromolecular Bioscience · 2026-09 · 26 (9)

DOI: 10.1002/mabi.70264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 21.09.2026. Verfasst von Debolina Basu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Tumor Suppressor Protein p53, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Indian Association for the Cultivation of Science (IACS), DST-Inspire, India and IACS, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorescent organic nanoparticles (FONPs) with intrinsic fluorescence and self‐assembled vesicles (VES) are receiving widespread interest in biomedicine. Both FONPs and VES have individual drawbacks like cytotoxicity of FONPs while VES gets eliminated through reticuloendothelial system impeding their applications. Development of nanoconjugates through amalgamation of individual nanocarrier with complementing features would find greater significance by overcoming individual hurdles. Herein, we report design and synthesis of FONP‐VES nanoconjugate by combining naphthalimide‐based pH‐responsive hydrazone moiety containing FONP ( NIHYDH ) and cholesterol‐based vesicle ( CBAV ) via electrostatic interaction. FONP, VES and FONP‐VES conjugate were characterized by spectroscopy and microscopy. Orange emitting NIHYDH‐CBAV nanoconjugate was utilised in bioimaging and as delivery vehicle which demonstrated targeted transport of tamoxifen (TAM) to (ER+) MCF7 cells through pH‐responsive dissipation of nanoconjugate owing to cleavage of hydrazone bond under acidic pH gradient. TAM has demonstrated clinical drug resistance along with limited bioavailability. Upon encapsulation within nanoconjugate, NIHYDH‐CBAV ‐TAM offered ∼2.8‐fold higher cytotoxicity toward MCF7 cells compared to normal NIH3T3 cells alongside demonstrating ∼2.1‐fold reduction in the size of MCF7 3D tumour spheroids. TAM loaded nanoconjugate was ∼2.2‐3.4‐fold more cytotoxic than TAM loaded individual nanocarrier. Cytotoxicity of NIHYDH‐CBAV ‐TAM got enhanced due to increased intracellular oxidative stress that triggered p53 upregulated cell apoptotic pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsTumor Suppressor Protein p53NanoparticlesNanoconjugatesHumansFemaleMCF-7 CellsAnimalsMiceHydrogen-Ion ConcentrationFluorescent Dyes

Stichwörter der Autor:innen

FONPnanoconjugatep53‐Breast cancertamoxifenvesicle

Substanzen

TamoxifenTumor Suppressor Protein p53NanoconjugatesFluorescent DyesTP53 protein, human

Autor:innen und Institutionen

  • School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata, India.

ORCID-Profile: Prasanta Kumar Das

Förderung

  • Indian Association for the Cultivation of Science (IACS)
  • DST-Inspire, India and IACS, India

Zitieren

APA

Basu, D., Roy, K., & Das, P. K. (2026). Tamoxifen Loaded Conjugate of Self‐Assembled Fluorescent Organic Nanoparticle and Vesicle for p53‐Activated Breast Cancer Therapy. Macromolecular Bioscience, 26(9). https://doi.org/10.1002/mabi.70264

Vancouver

Basu D, Roy K, Das PK. Tamoxifen Loaded Conjugate of Self‐Assembled Fluorescent Organic Nanoparticle and Vesicle for p53‐Activated Breast Cancer Therapy. Macromolecular Bioscience. 2026;26(9). doi:10.1002/mabi.70264

BibTeX
@article{Basu2026,
  author = {Basu, Debolina and Roy, Kathakoli and Das, Prasanta Kumar},
  title = {Tamoxifen Loaded Conjugate of Self‐Assembled Fluorescent Organic Nanoparticle and Vesicle for p53‐Activated Breast Cancer Therapy},
  journal = {Macromolecular Bioscience},
  year = {2026},
  volume = {26},
  number = {9},
  doi = {10.1002/mabi.70264}
}
Kostenlos starten →